Besides their known slow genomic effects, testosterone and estradiol have rapid effects in the brain. However, their impact on mood-related behavior is not clear. The aim of this study was to investigate the non-genomic pathway of testosterone and estradiol in the amygdala in relation to anxiety and depressive-like behavior. Sham-operated and gonadectomized male rats (GDX) supplemented with testosterone propionate, estradiol, or olive oil were used. Five minutes after administration, anxiety and depression-like behavior were tested. Estradiol increased anxiolytic behavior in the open-field test compared to the GDX group, but administration of testosterone had no significant effect. Besides, c-Fos expression in the medial nucleus of the amygdala significantly increased after testosterone treatment compared to the GDX group, while no significant difference was observed in the central and the basolateral nuclei of the amygdala in the testosterone-treated group compared to the GDX group. In conclusion, estradiol had an anxiolytic effect via a rapid pathway, but no rapid effect of testosterone on anxiety was found. Further studies elucidating whether the rapid effect is mediated by a non-genomic pathway are needed.
INTRODUCTION
The effects of sex hormones are largely mediated by intracellular receptors. Steroid hormone receptors belong to a large group of ligand-activated transcription factors that bind to specific DNA sequences and modulate the transcription of genes encoding a wide variety of proteins.
These genomic effects of sex hormones are relatively slow and usually appear after one hour to several days [1] .
The genomic mechanism seems to play a role in the longterm effects of hormones on tissues sensitive to steroids, such as the brain. The effects of steroids on the nervous system are limited to cells that contain intracellular steroid receptors. Moreover, the effects of these receptors may also induce other processes, for example, induction of key metabolic enzymes of neurotransmitter metabolism [2] .
Apart from the slow genomic effects of steroids, rapid effects have also been described. These effects are too fast to activate DNA transcription and translation (within a few seconds to minutes). Therefore, they are also referred to as non-genomic effects [3] . Studies of in vivo and in vitro models have shown that nuclear receptors, which are activated by binding to hormones, interact with other transcription factors without direct binding to DNA [3] . The kinase C, and mitogen-activated protein kinase [4] . The induction of secondary messengers via the non-genomic effects of steroids is insensitive to transcription and translation inhibitors.
Testosterone, its metabolite 5α-dihydrotestosterone, and estradiol affect anxiety, depressive-like behavior, and memory. Results from animal studies suggest that testosterone has antidepressant [5, 6] and anxiolytic effects [6, 7] .
Carrier and Kabbaj found that testosterone significantly decreases depressive-like behavior of male rats in forced swim tests. Since behavioral despair is reversed by estradiol benzoate but not dihydrotestosterone, the authors concluded that this effect is probably mediated by the aromatization of testosterone to estradiol [5] . Similar results have been found in experiments with mice. Older male mice spend more time immobile than older females. Depressivelike behavior is reduced in both sexes compared to controls upon receiving testosterone, dihydrotestosterone, 5α-androstane-3α,17β-diol, and estradiol [8] .
The anxiolytic effects of testosterone are well known in rats [9] and mice [10] . However, the underlying mechanism is not well understood. Removal of the primary source of endogenous androgens (castration) in male rats increases anxiety behavior in the elevated plus maze and open-fi eld tests [11] . In contrast, repeated injections of testosterone into castrated rats reduce anxiety behavior in probeburying tests [12] , but this behavior does not occur after administration of 3α-androstanediol and 5α-androstane-3α, 17β-diol (3α-and 5α-reduced metabolites of testosterone, respectively).
Estradiol has positive effects on reference memory in aging mice [13] and can decrease anxiety and depressivelike behavior [14] . However, the results from various studies are in conflict. For example, in adult female meadow voles, estradiol impairs spatial performance and increases depressive-like behavior [15] . Treatment of mice with estradiol benzoate increases anxiety in the open-fi eld, elevated plus maze, and light-dark transition tests, as well as activity in running wheels, compared to vehicle administration [16] . In Also, application of estradiol to the hippocampus in rats for 10 min following training improves performance in hippocampus-mediated tasks [17] . These inconsistencies may be caused by differences in the doses of estradiol, duration of exposure, and activity of the hypothalamicpituitary-adrenal axis [14] , or by unclear differences between the genomic and non-genomic effects of steroid hormones [6] .
Steroids affect neurons, glial cells, sexually dimorphic nuclei, and soma size in various brain regions, including the amygdala and hippocampus [18] . [19] . For example, the expression of full-length mRNA of the c-Fos gene is evident within 5-10 min after stimulation, with subsequently detectable c-Fos protein within 30-45 min [20] .
The amygdala is a key structure in anxiety/fear regulation. This region is often studied in the context of emotion-processing and anxiogenic behavior, but the neuronal mechanisms that control these processes are still unclear [21] . The amygdala is rich in androgen receptors [22] while also containing both alpha and beta estrogen receptors [23] . The amygdala is affected by the circulating level of testosterone, and androgen receptors located in axons in this region play an important role in the rapid behavioral effects of androgens [24] .
Although doubts regarding the existence of nongenomic steroid effects have disappeared, their role in anxiety and/or depressive behavior is not fully understood.
In this study, we examined the behavioral changes induced by the steroid hormones testosterone and estradiol and Fluka, Sigma Aldrich). The doses of testosterone [9] and estradiol [25] were based on previous experiments. Hormonal supplementation and olive oil vehicle administration were performed by the same experimenter in the room where the animals were housed.
Behavioral Testing
All behavioral tests were conducted during the light phase of the cycle (09:00 -12:00 [26, 27] . The behavioral testing lasted for 5 consecutive days (6 animals per day).
Open-Field Test
The arena measured 100 × 100 cm 2 in area, 40 cm in height, and was placed in a dark room, with the middle of the maze well illuminated. The walls and fl oor of the arena were painted black inside and white outside. Rats were placed in the middle of the maze and allowed to freely explore for 5 min. The time spent in the center, near the walls, and in the corners of the maze was determined.
Ethovision XT 8.5 tracking software (Noldus, Netherlands) was used to defi ne a 40 × 40 cm 2 virtual central zone. More time spent in the illuminated center of the maze reflects less anxious behavior [28] .
Simple Novelty Object Recognition
The arena was the same as that used in the open-field test. However, a new object was placed in one corner of the arena. Cone-shaped cups were used as target stimuli.
The rats were allowed to move freely for 5 min and the time spent interacting with the new object was recorded. Sniffi ng or touching the object with the nose while running around the object was considered the criterion for interaction. More time interacting with the new object reflects less anxiety and higher exploration-derived behavior [29] .
Light-Dark Box
The light-dark box arena was 80 × 40 cm 2 in area and 40 cm in height, divided into well-illuminated and dark halves, the latter covered by a roof. The two parts of the arena were separated by a black wall with an entrance. The rats were placed in the illuminated part facing the wall for 5 min and the time spent in the illuminated part and the number of entrances/exits to the dark half were recorded. More time spent in the illuminated part of the box reflects less anxiety [30] .
Forced-Swim Test
Depression-like behavior was assessed using the Porsolt forced-swim test. Rats were placed in a 80-cm tall Plexiglas cylinder fi lled with 24 ± 1°C water, from which the animals could not escape, for 3 min. Every 5 s, one of three forms of behavior was recorded: climbing, defi ned as rats trying to escape the cylinder; swimming, defi ned as rats performing circular movements; and immobility, defined as floating on the water without other movements. Immobility time corresponds to depression-like behavior [31] .
Hormone Assays
After the last test, blood samples were obtained immediately after decapitation. The concentrations of testosterone and estradiol in plasma were determined using commercial ELISA kits (DRG Diagnostics, Marburg, Germany).
Immunohistochemistry
Immediately after behavioral testing, rats were anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine and 
Statistical Analysis
Data are presented as mean ± standard error (SE), and were analyzed by one-way analysis of variance (ANOVA) with Tukey's post-hoc test. Signifi cance was assigned to a value of P <0.05.
RESULTS
We found higher testosterone levels in the GDX + T group than in the GDX group (F = 76.74, P <0.001, Fig. 1A ).
Similarly, higher concentrations of estradiol were found in the GDX + E group than in the GDX group (F = 66.86, P < 0.001, Fig. 1B ). There were also signifi cant differences in testosterone levels between the GDX+T and GDX+E groups.
Behavioral Tests
In the open-fi eld test, the GDX + E group spent more time in the central zone than the GDX group (F = 3.55, P <0.05, Fig. 2A ). Administration of testosterone had no effect on behavior. In simple novelty recognition, no significant differences were found between the groups (F = 0.24, P = 0.86, Fig. 2B ). In the light-dark box test, both the GDX + T and GDX + E groups showed a trend of spending less time in the illuminated zone compared to the GDX group (F = 2.87, P = 0.06, Fig. 2C ). In the forced-swim test, neither estradiol nor testosterone supplementation had any effect on the immobility time compared with the GDX group (F = 1.11, P = 0.36, Fig. 2D ).
c-Fos-Expressing Neurons
c-Fos-stained neurons were visible in photomicrographs (Fig. 3) . In the MeA, the number of c-Fos immunoreactive Fig. 4A ). In the CeA and BLA, we found no differences in c-Fos cell numbers in the GDX + T and GDX + E groups compared to the GDX group ( Fig. 4B and C) .
DISCUSSION
Our results showed that estradiol had a rapid anxiolytic effect on male rat behavior in the open field test. In the other tests, we found no significant differences after estradiol supplementation. Application of testosterone reported an anxiolytic effect [7, 9, 10] . A study by Aikey et al.
showed that testosterone administration rapidly (30 min after application) reduces anxiety in male mice in the elevated plus maze. This anxiolytic effect is mediated by conversion of testosterone to reduced metabolites that interact with GABA A receptors. Also, dihydrotestosterone application results in anxiolytic effect, while estradiol does not [10] . Similar results were found in male rats. Gonzalez et al. [33] reported that castration of male rats is anxiogenic and testosterone treatment is anxiolytic. In contrast, Minkin et al. [34] found that treatment with nandrolone decanoate increases anxiety in gonadally intact and gonadectomized rats. Their study involved long-term (8-week) treatment, allowing for the study of genomic effects. In contrast, many authors have suggested that the genomic effects of testosterone on behavior are anxiolytic and mediated via the androgen receptor [7, 9, 10] .
Estrogens can have direct non-genomic effects on neuronal membranes and thus affect neuronal activity.
They can be produced locally by the aromatization of testosterone in presynaptic terminals and their production can be modulated within minutes by calcium-dependent phosphorylation [35] . There is evidence that estradiol induces anxiolytic behavior [16, 36] . The non-genomic effects of estradiol have been studied by Trainor et al. [37] . Estradiol has rapid effects on the behavior of male deer mice (Peromyscus sp.) in long (16 h light:8 h dark) and winter-like short days (8 h light:16 h dark). Estradiol injection into male P. polionotus experiencing short days increases aggressive behavior within 15 min [37] , but there is no signifi cant effect on behavior during long days. These results suggest that estradiol increases aggression during short days in mice by activation of a non-genomic mechanism, as it is generally thought that 15 min is insufficient for gene expression changes mediated by estrogen receptors [38] . Results from these studies indicate that estradiol can quickly influence behavior, which is in accord with our study. Furthermore, aggressive behavior could be associated with reduced anxiety.
c-Fos expression is a good indicator of neuronal activity. There is some evidence for a direct correlation between anxiety and c-Fos induction in brain areas, including the MeA, of young adult rats [39] . In our study, testosterone application to castrated rats increased c-Fos expression in the MeA without affecting the CeA and BLA. These results are not in line with our findings from behavioral testing, since administration of estradiol had no effect on the number of c-Fos-immunoreactive cells in the amygdala. However, non-genomic effects of steroids occurring within seconds to minutes after hormonal stimulation are too rapid for protein synthesis [40] .
Finally, induction of c-Fos protein requires transcriptional activation. Thus, in some sense, the presence of c-Fos represents a genomic response to stimulation by sex steroids such as testosterone [41] . Kovacs and Sawchenko reported the highest c-Fos expression between 1 and 2 h after stimulation [42] , which suggests that 30 min after steroid application is not sufficient time for quantification of the effect of steroids on the number of c-Fos-positive cells.
Although c-Fos is often used as a marker for non-genomic action, the role of steroid receptors other than those in the intracellular milieu cannot be excluded in this rapid effect.
There is evidence that non-genomic effects of steroids are mediated via estrogen and androgen receptors and this action can interact with slow genomic infl uence in the brain [3, 43] . This is indeed a major limitation of our study, and our further studies will use antagonists of androgen and estrogen receptors to distinguish between the genomic and non-genomic actions of steroids.
Furthermore, some work suggests that the rapid effect of testosterone is mediated via its aromatization into estradiol. Brain aromatase activity can quickly change, and this may rapidly infl uence the behavior of male mice [44, 45] .
Some studies also suggest that the non-genomic effects of testosterone require high concentrations of this hormone [44] .
Castration decreases testosterone concentrations in the brain to an undetectable level. Nevertheless, in this study, testosterone supplementation raised its concentration to ~3-fold the control level. On the other hand, injection of estradiol into castrated male rats increases the precopulatory and copulatory behavior of receptive females.
This effect occurs 15 min after estradiol exposure. In contrast, application of testosterone is ineffective [46] .
However, a short-latency effect of testosterone on copulatory behavior occurs when testosterone is applied to intact male rats [47] . The ineffectiveness of testosterone in the study of Cross and coauthors might have been due to the castrated status of the males. We found similar In conclusion, anxiolytic behavior was observed in estradiol-supplemented male rats, which suggest a rapid effect of estradiol. At least to some extent, this could be explained by the need for aromatization of testosterone to estradiol, which could require a longer time to take effect.
Testosterone seemed not to have a direct effect on the anxiety level. Neither testosterone nor estradiol seemed to affect the depression-like behavior. Blockade of androgen and estrogen receptors in future studies should help to extend the time-window for non-genomic infl uences of sex steroids on anxiety behavior.
